U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3507135071Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic HyperplasiaRecruitingNo Results AvailableNocturia|Benign Prostatic HyperplasiaDrug: Silodosin|Other: Laboratory tests|Other: 3-days voiding diary|Other: 12 weekshttps://ClinicalTrials.gov/show/NCT02106182
3507235072Impact of the Therapeutic Education on the Quality of Life of the Child Suffering of Food Allergy IgE-mediatedRecruitingNo Results AvailableIgE Mediated Food AllergyBehavioral: Therapeutic education grouphttps://ClinicalTrials.gov/show/NCT02106169
3507335073Observational Study Evaluating the Quality of Pegasys and Copegus Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologists)CompletedNo Results AvailableChronic Hepatitis Chttps://ClinicalTrials.gov/show/NCT02106156
3507435074RejuvenAirâ„¢ System Lobectomy Safety and Histology StudyTerminatedNo Results AvailableLung Neoplasms|Airway Obstruction|Lung CancerDevice: RejuvenAirâ„¢ Radial Spray Cryotherapyhttps://ClinicalTrials.gov/show/NCT02106143
3507535075A Drug Interaction Study of Mosapride and RebamipideCompletedNo Results AvailableHealthyDrug: Rebamipide|Drug: Mosapride citratehttps://ClinicalTrials.gov/show/NCT02106130
3507635076Exhaled Breath Analysis in the Early Detection of AspergillosisRecruitingNo Results AvailableInvasive Aspergillosishttps://ClinicalTrials.gov/show/NCT02106117
3507735077Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 DiabetesRecruitingNo Results AvailableType 2 DiabetesDrug: Linagliptin 5 mg QD|Drug: Glimepiride 1 mg QDhttps://ClinicalTrials.gov/show/NCT02106104
3507835078Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHLRecruitingNo Results AvailableRelapsed B-Cell Non-Hodgkin Lymphoma|Refractory B-Cell Non-Hodgkin LymphomaDrug: AFM11https://ClinicalTrials.gov/show/NCT02106091
3507935079Internet-Based Interventions for Bipolar DisorderActive, not recruitingNo Results AvailableBipolar DisorderBehavioral: Moderated Discussion Board|Behavioral: Psychoeducation|Behavioral: Interactive Psychosocial Toolshttps://ClinicalTrials.gov/show/NCT02106078
3508035080VA Cultivating Access to Resources, Education, and Skills for Dementia CaregiversRecruitingNo Results AvailableDementia|Caregivers|Neurodegenerative Diseases|Brain DiseasesBehavioral: Education and Skill-Building Rehabilitation (ESBR)|Other: Supplemental Education Materialshttps://ClinicalTrials.gov/show/NCT02106065
3508135081Study of Exercise on Impact of Cognitive Functioning in Multiple Sclerosis PatientsRecruitingNo Results AvailableMultiple SclerosisOther: Aerobic exercise|Other: Stretching and toning exercisehttps://ClinicalTrials.gov/show/NCT02106052
3508235082Pulmonary Tuberculosis Patients With Diabetes MellitusRecruitingNo Results AvailableDiabetes Mellitus|Pulmonary TuberculosisProcedure: intensive monitoringhttps://ClinicalTrials.gov/show/NCT02106039
3508335083Nursing Education Intervention for Maternal BreastfeedingCompletedNo Results AvailableBreast Feeding|Postpartum Breast DisordersOther: Preventive educationhttps://ClinicalTrials.gov/show/NCT02106026
3508435084Association Between HDL Functions and Atherosclerotic Burden in Healthy IndividualsCompletedNo Results AvailableLow HDL Cholesterolhttps://ClinicalTrials.gov/show/NCT02106013
3508535085A Non-investigational Product (IP) Study to Investigate Lung Function in Women in the Third Stage of LabourCompletedNo Results AvailableHaemorrhageDevice: Inhalation profile recorderhttps://ClinicalTrials.gov/show/NCT02106000
3508635086A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral RegimenActive, not recruitingNo Results AvailableInfection, Human Immunodeficiency VirusDrug: ABC/DTG/3TC FDC|Drug: Ongoing cART regimenhttps://ClinicalTrials.gov/show/NCT02105987
3508735087Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Fluticasone Furoate/Vilanterol|Drug: Vilanterolhttps://ClinicalTrials.gov/show/NCT02105974
3508835088Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)RecruitingNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Mepolizumab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02105961
3508935089Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) PatientsRecruitingNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Mepolizumab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02105948
3509035090Investigator Initiated Protocol for the: Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNAâ„¢) Technology in the Management of Sport Related Concussion and the Establishment of Normative Data in Youth and Adolescents AtRecruitingNo Results AvailableNormative|Concussedhttps://ClinicalTrials.gov/show/NCT02105935
3509135091Effect of Strength Training and Protein Ingestion in Old Versus Very-oldRecruitingNo Results AvailableSarcopenia|Muscle LossProcedure: Heavy Resistance Training|Procedure: Light Intensity Training|Procedure: Protein Wheyhttps://ClinicalTrials.gov/show/NCT02105922
3509235092GWAS in a Small Group of Metabolically Healthy Obese White AdultsCompletedNo Results AvailableObesityOther: GWAShttps://ClinicalTrials.gov/show/NCT02105909
3509335093Clinical Evaluation of Total-Etch and Self-Etch Dental Adhesives - 6 Year RecallCompletedNo Results AvailableDental Bondinghttps://ClinicalTrials.gov/show/NCT02105896
3509435094The Effect of Identification Badge on Situation Awareness During High Fidelity SimulationCompletedNo Results AvailablePatient Simulation|Awareness|Reality Testing|ResidencyOther: Use of identification badge during scenarioshttps://ClinicalTrials.gov/show/NCT02105883
3509535095A Randomized Trial of Intracoronary Reopro to Improve Coronary Microvascular FunctionActive, not recruitingNo Results AvailableMyocardial Infarction|Coronary Artery DiseaseDrug: Abciximabhttps://ClinicalTrials.gov/show/NCT02105870
3509635096The Effects of End-of-range Grade A+ Mobilization Following Acute Primary TKACompletedNo Results AvailableOsteoarthritis, KneeOther: grade A+ knee mobilizationhttps://ClinicalTrials.gov/show/NCT02105857
3509735097Swiss Atrial Fibrillation Cohort StudyRecruitingNo Results AvailableAtrial Fibrillationhttps://ClinicalTrials.gov/show/NCT02105844
3509835098Skeletal Muscle Perfusion With LVADRecruitingNo Results AvailableHeart FailureOther: Contrast ultrasound skeletal muscle perfusion imaginghttps://ClinicalTrials.gov/show/NCT02105831
3509935099Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic SclerosisCompletedNo Results AvailableSystemic Sclerosis [Scleroderma]|Deglutition Disorders|Adherence to Medication Regime|Coping Behaviourhttps://ClinicalTrials.gov/show/NCT02105818
3510035100Weight Loss as Treatment in Heart DiseaseCompletedNo Results AvailableHeart FailureBehavioral: Dietetic group sessionshttps://ClinicalTrials.gov/show/NCT02105805

* Görseller ve İçerik tekif hakkına sahip olabilir